proline has been researched along with Lymphoma, T-Cell in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bhanap, BA; Niedzwiecki, A; Rath, M; Roomi, MW; Roomi, NW | 1 |
| D'Alessandro, N; Dusonchet, L; Meli, M; Notarbartolo, M; Rausa, L; Tolomeo, M | 1 |
| Aster, JC; Fletcher, JA; McCarthy, JG; Xiao, S | 1 |
3 other study(ies) available for proline and Lymphoma, T-Cell
| Article | Year |
|---|---|
Antineoplastic effects of nutrient mixture on raji and jurkat t cells: the two highly aggressive non Hodgkin's lymphoma cell lines.
Topics: Antineoplastic Agents; Apoptosis; Ascorbic Acid; Burkitt Lymphoma; Cell Proliferation; Collagen; Drug Combinations; Humans; Laminin; Lymphoma, T-Cell; Lysine; Matrix Metalloproteinase 9; Neoplasm Invasiveness; Proline; Proteoglycans; Tea; Tumor Cells, Cultured | 2009 |
NF-kappaB inhibition restores sensitivity to Fas-mediated apoptosis in lymphoma cell lines.
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; fas Receptor; Humans; Leupeptins; Lymphoma, T-Cell; NF-kappa B; Peptides; Proline; Thiocarbamates | 2003 |
ZNF198-FGFR1 transforming activity depends on a novel proline-rich ZNF198 oligomerization domain.
Topics: Animals; Binding Sites; Carrier Proteins; Cell Transformation, Neoplastic; DNA-Binding Proteins; Enzyme Activation; Hematopoietic Stem Cells; Lymphoma, T-Cell; Macromolecular Substances; Mice; Phosphorylation; Phosphotyrosine; Proline; Receptor Protein-Tyrosine Kinases; Receptor, Fibroblast Growth Factor, Type 1; Receptors, Fibroblast Growth Factor; Recombinant Fusion Proteins; Structure-Activity Relationship; Transcription Factors; Tumor Cells, Cultured | 2000 |